Cargando…
Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation
Mutations in the granulin (GRN) gene, resulting in haploinsufficiency of the progranulin (PGRN) protein, are a leading cause of frontotemporal lobar degeneration (FTLD) and PGRN polymorphisms are associated with Alzheimer’s disease (AD) and Parkinson’s disease (PD). PGRN is a key regulator of microg...
Autores principales: | Du, Huan, Yang, Cha, Nana, Alissa L., Seeley, William W., Smolka, Marcus, Hu, Fenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104136/ https://www.ncbi.nlm.nih.gov/pubmed/37066328 http://dx.doi.org/10.1101/2023.04.06.535844 |
Ejemplares similares
-
Inhibition of sPLA(2)-IIA Prevents LPS-Induced Neuroinflammation by Suppressing ERK1/2-cPLA(2)α Pathway in Mice Cerebral Cortex
por: Xiang, Yanxiao, et al.
Publicado: (2013) -
Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis
por: Li, Kaijun, et al.
Publicado: (2010) -
The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults—A systematic review
por: Tan, Toh Leong, et al.
Publicado: (2017) -
Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA
por: Dong, Tianyi, et al.
Publicado: (2017) -
Modulation of Airway Expression of the Host Bactericidal Enzyme, sPLA2-IIA, by Bacterial Toxins
por: Wu, Yongzheng, et al.
Publicado: (2023)